A webinar explaining the background to the PBAC decision to remove the CD4>500 prescribing criteria for ART initiation. Levinia Crooks, ASHM CEO outlines the process and persons involved in the submission.
Former ASHM President Associate Professor Edwina Wright, Alfred Hospital, Monash University, and The Burnet Institute then covers the clinical rationale behind the PBAC decision and the implications this will have ART prescribing in Australia.
Target audience: HIV s100 Prescribers, General Practitioners, health professionals, policy makers and health promotion staff working with people with HIV.
CPD: 2 HIV CPD
Type: Webinar (2014)
Funded by: NSW Health